| The economic burden of schizophrenia in the United States in 2002 EQ Wu, HG Birnbaum, L Shi, DE Ball, RC Kessler, M Moulis, J Aggarwal Journal of Clinical Psychiatry 66 (9), 1122-1129, 2005 | 958 | 2005 |
| The prevalence and correlates of nonaffective psychosis in the National Comorbidity Survey Replication (NCS-R) RC Kessler, H Birnbaum, O Demler, IRH Falloon, E Gagnon, M Guyer, ... Biological psychiatry 58 (8), 668-676, 2005 | 474 | 2005 |
| Concordance of adherence measurement using self-reported adherence questionnaires and medication monitoring devices L Shi, J Liu, Y Koleva, V Fonseca, A Kalsekar, M Pawaskar Pharmacoeconomics 28, 1097-1107, 2010 | 255 | 2010 |
| Correlation between adherence rates measured by MEMS and self-reported questionnaires: a meta-analysis L Shi, J Liu, V Fonseca, P Walker, A Kalsekar, M Pawaskar Health and quality of life outcomes 8, 1-7, 2010 | 223 | 2010 |
| Annual prevalence of diagnosed schizophrenia in the USA: a claims data analysis approach EQ Wu, L Shi, H Birnbaum, T Hudson, R Kessler Psychological medicine 36 (11), 1535-1540, 2006 | 222 | 2006 |
| Impact of a natural disaster on diabetes: exacerbation of disparities and long-term consequences VA Fonseca, H Smith, N Kuhadiya, SM Leger, CL Yau, K Reynolds, L Shi, ... Diabetes care 32 (9), 1632-1638, 2009 | 204 | 2009 |
| The burden of hypoglycemia on healthcare utilization, costs, and quality of life among type 2 diabetes mellitus patients SA Williams, L Shi, SK Brenneman, JC Johnson, JC Wegner, V Fonseca Journal of Diabetes and its Complications 26 (5), 399-406, 2012 | 148 | 2012 |
| Economic burden and quality of life of vulvodynia in the United States Y Xie, L Shi, X Xiong, E Wu, C Veasley, C Dade Current medical research and opinion 28 (4), 601-608, 2012 | 141 | 2012 |
| Characteristics and use patterns of patients taking first-generation depot antipsychotics or oral antipsychotics for schizophrenia L Shi, H Ascher-Svanum, B Zhu, D Faries, W Montgomery, SR Marder Psychiatric services 58 (4), 482-488, 2007 | 137 | 2007 |
| Reduced mortality in cystic fibrosis patients treated with tobramycin inhalation solution GS Sawicki, JE Signorovitch, J Zhang, D Latremouille‐Viau, ... Pediatric pulmonology 47 (1), 44-52, 2012 | 135 | 2012 |
| Impact of hypoglycemia associated with antihyperglycemic medications on vascular risks in veterans with type 2 diabetes Y Zhao, CR Campbell, V Fonseca, L Shi Diabetes care 35 (5), 1126-1132, 2012 | 131 | 2012 |
| Good research practices for measuring drug costs in cost effectiveness analyses: issues and recommendations: the ISPOR Drug Cost Task Force Report—Part I JW Hay, J Smeeding, NV Carroll, M Drummond, LP Garrison, EC Mansley, ... Value in Health 13 (1), 3-7, 2010 | 126 | 2010 |
| Health-related quality of life of “left-behind children”: a cross-sectional survey in rural China Z Jia, L Shi, Y Cao, J Delancey, W Tian Quality of Life Research 19, 775-780, 2010 | 117 | 2010 |
| The impact of unrecognized bipolar disorders for patients treated for depression with antidepressants in the fee-for-services California Medicaid (Medi-Cal) program L Shi, P Thiebaud, JS McCombs Journal of affective disorders 82 (3), 373-383, 2004 | 117 | 2004 |
| Economic consequences of not recognizing bipolar disorder patients: a cross-sectional descriptive analysis HG Birnbaum, L Shi, E Dial, EF Oster, PE Greenberg, DA Mallett Journal of Clinical Psychiatry 64 (10), 1201-1209, 2003 | 116 | 2003 |
| Effect of metformin on neurodegenerative disease among elderly adult US veterans with type 2 diabetes mellitus Q Shi, S Liu, VA Fonseca, TK Thethi, L Shi BMJ open 9 (7), e024954, 2019 | 115 | 2019 |
| Safety and efficacy of glargine compared with NPH insulin for the treatment of Type 2 diabetes: a meta‐analysis of randomized controlled trials LA Bazzano, LJ Lee, L Shi, K Reynolds, JA Jackson, V Fonseca Diabetic Medicine 25 (8), 924-932, 2008 | 115 | 2008 |
| A systematic review of the direct economic burden of type 2 diabetes in China H Hu, M Sawhney, L Shi, S Duan, Y Yu, Z Wu, G Qiu, H Dong Diabetes Therapy 6, 7-16, 2015 | 108 | 2015 |
| Classifying patients by antipsychotic adherence patterns using latent class analysis: characteristics of nonadherent groups in the California Medicaid (Medi-Cal) program J Ahn, JS McCombs, C Jung, TJ Croudace, D McDonnell, ... Value in Health 11 (1), 48-56, 2008 | 100 | 2008 |
| Cost-effectiveness of atezolizumab plus bevacizumab vs sorafenib as first-line treatment of unresectable hepatocellular carcinoma D Su, B Wu, L Shi JAMA Network Open 4 (2), e210037-e210037, 2021 | 98 | 2021 |
